Menu
Search
|

Menu

Close
X

Heska Corp HSKA.OQ (NASDAQ Stock Exchange Capital Market)

101.43 USD
+1.86 (+1.87%)
As of Nov 16
chart
Previous Close 99.57
Open 98.90
Volume 14,537
3m Avg Volume 13,676
Today’s High 101.43
Today’s Low 98.90
52 Week High 114.50
52 Week Low 56.76
Shares Outstanding (mil) 7.59
Market Capitalization (mil) 741.92
Forward P/E 101.06
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.86 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY18
93
FY17
126
FY16
130
FY15
105
EPS (USD)
FY18
0.292
FY17
2.121
FY16
1.420
FY15
0.753
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
101.06
29.34
Price to Sales (TTM)
vs sector
5.86
20.58
Price to Book (MRQ)
vs sector
6.62
4.23
Price to Cash Flow (TTM)
vs sector
62.59
21.19
Total Debt to Equity (MRQ)
vs sector
5.39
13.84
LT Debt to Equity (MRQ)
vs sector
0.00
9.93
Return on Investment (TTM)
vs sector
6.25
13.58
Return on Equity (TTM)
vs sector
6.78
15.11

EXECUTIVE LEADERSHIP

Sharon Larson
Independent Chairman of the Board, Since 2015
Salary: --
Bonus: --
Kevin Wilson
President, Chief Executive Officer, Director, Since 2017
Salary: $302,083.00
Bonus: --
Jason Napolitano
Chief Operating Officer, Chief Strategist and Secretary, Since 2016
Salary: $350,000.00
Bonus: --
Steven Eyl
Executive Vice President - Global Sales and Marketing, Since 2016
Salary: $300,000.00
Bonus: --
Steven Asakowicz
Executive Vice President - Companion Animal Health Sales, Since 2013
Salary: $175,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

3760 Rocky Mountain Ave
LOVELAND   CO   80538-7084

Phone: +1970.4937272

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.

SPONSORED STORIES